Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Health Catalyst, Inc (HCAT) is a company in the Technology sector; its shares trade on Nasdaq.
The price of Health Catalyst, Inc (HCAT) on November 13, 2026 is 1.51 $, +11.03 % on the day. Over 52 weeks the stock traded between 0.9550 $ and 3.02 $; the price now sits 27 % of the way up that range. Over the past year the price changed by −38.62 %. Market capitalization is 112.64 million $, rank 36 among 47 stocks of the same industry with a known capitalization.
Health Catalyst, Inc trades on Nasdaq under the ticker HCAT. The company belongs to the Technology sector. The trading history on this page starts on 25 July 2019.
Over the past 52 weeks HCAT has traded between 0.9550 $ and 3.03 $. As of 13 November 2026 the price stood 26.81% of the way from the 52-week low to the high.
Over one year HCAT shares fell 35.74%; over six months they rose 26.89%. Volatility over 90 days is 78.26%. Dividends are not included: this is price change only, as of 13 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 0.4, below the sector median of 3.3. Price to book is 1.1, below the sector median of 3.3. Calculated from reports for the period ending 30 June 2026.
Health Catalyst, Inc reported revenue of 292M $ and a net loss of 265M $ over the last four quarters. Net margin is −90.61%. Revenue changed by −7.54% year over year. Earnings per share are −$3.68. Market capitalisation is 113M $.
HCAT has a return on equity of −262.64%, below the sector median of 2.27%. Return on assets is −73.85%, below the sector median of 0.67%. Operating margin is −84.36%, below the sector median of 1.05%.